Published January 15, 2018 | Version v.1
Journal article Open

miRNAs as Potential Treatment Targets and Treatment Options in Cancer

  • 1. University of Belgrade, Vinca Institute of Nuclear Sciences, Mike Petrovica Alasa 12-14, 11001, Belgrade, Serbia; Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000, Belgrade, Serbia
  • 2. Ulubey Vocational Higher School, Ordu University, 52850, Ordu, Turkey; Department of Medical Biology, Faculty of Medicine, Ondokuz Mayis University, 55139, Samsun, Turkey

Description

Standard cancer therapies for solid malignancies, such as chemotherapy and radiotherapy, are not target specific against cancer cells and are often not fully efficacious. Chemotherapy and radiotherapy may cause side effects, and the need to develop additional strategies for cancer treatment is urgent. MicroRNAs (miRNAs) are small non-coding RNAs with heterogeneous functions and have been described in almost every known cancer model. Besides their basic tumor-suppressive and oncogenic functions, they also have the potential to modulate chemotherapy and radiotherapy and to be manipulated with chemical compounds to make them chemically suitable for efficient delivery to cancer cells. It has been suggested that the level of expression of specific miRNAs could increase treatment efficacy by determining the stage of chemotherapy/radiotherapy sensitivity. Application of miRNAs alone or in combination with standard therapeutic strategies may significantly improve the success of cancer treatments in the future.

Notes

This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that during the production process, errors may be discovered which could not affect the content. This work was supported by Ministry of Education and Science, Republic of Serbia, Grants OI173049, OI175011, and by Ordu University, Scientific Research Projects Coordination Unit.

Files

MicroRNA heterogeneity as a Drug target and Treatment Option in Cancer. pdf.pdf

Additional details

Identifiers

Funding

Molecular determinants for tumor marker design 173049
Ministry of Education, Science and Technological Development
Biological response modifiers in physiological and pathological conditions 175011
Ministry of Education, Science and Technological Development